Home » China Venture Capital »

|| Chinese Decheng Capital and consortium invested $120 million in California genetics firm

decheng usDecheng Capital, a China healthcare investment firm, and a group of other investors announced investment of $120 million in San Francisco genetics firm Invitae.

Invitae is a genetic information company and has raised a total of $207 million from investors to date. It provides a single diagnostic test comprising over 200 genes for $1,500. Decheng Capital, based in Shanghai, provides capital to early and growth stage life science companies and already has stakes in other firms like GeneWeave, GenapSys, SentreHeart, 3SBio, Shenzhen GeneMDx Biotech and SINO Medical Sciences.

To see listing and email addresses of investors from China similar to Decheng Capital, check the Chinese Investors Directory

More details follows

Previous Post: China's Anbang acquired Hilton's NY Waldorf for $1.95 billion
Next Post: Chinese investors led $70 million investment in San Francisco education firm Minerva

More from China Venture Capital ...

  Chinese VC firm Acacia and consortium acquired stake in Mexican startup for $5.3 million

  Chinese investors of NLVC acquired stake in California startup for $7 million

  Chinese investors of Yunqi acquired stake in German startup Jina for $5.4 million

  Chinese investors of Linear Capital acquired stake in Singapore Igloo for $8.2 million

  Chinese investor Justin Sun acquired BitTorrent for $140 million

  China NetDragon to acquire California firm Edmodo for $137 million

  Chinese firm invests $100 million in New Zealand gaming company

  Chinese firm Fosun invests $5 million in Israeli fintech startup

  Chinese VC firm Matrix Partners China has raised $750 million for its fund

  Chinese investors of Leyou acquired 20% of US game developer for $10 million

| About Us

SinaBeat.com provides insight, analysis and research on private investors from China since 2012.

We cover Private Equity, Venture Capital, Real Estate and Institutional Investors from China, Hong Kong and Macau.

Our Chinese Investors Directory can be used as a reliable source on information about investors from China.

|Subscribe to mailing list

Careers  |  Sponsorship |  Sitemap |  Terms  |  Privacy Policy

Copyright 2007 - 2023     SinaBeat.com

Follow us: RSS  |   SinaBeat on Twitter  |   SinaBeat on Facebook  |   SinaBeat on LinkedIn

Powered by Insightice